Responses

PDF

Long term follow up of patients treated for Helicobacter pylori infection
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Association of preneoplastic gastric lesions and H. pylori
    • Shamsul A Bhuiyan,MD
    • Other Contributors:
      • Dr. Carlos Javier Mencias Vera, MD, Mount Sinai School of Medicine (Cabrini)

    Dear Editor,

    In 1994, Helicobacter pylori was declared a type 1 carcinogen—a definite cause of human cancer—by the International Agency for Research on Cancer (IARC).[1]

    We read with interest the study by Mera et al.[1] on the effect of eradicating H. pylori infection on precancerous gastric lesions. Here the author Mera et al conclude that “Preneoplastic gastric lesions regress at a rate equal to the squ...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Effect of H. pylori eradication on precancerous lesions
    • Derek Gillen, Consultant Gastroenterologist
    • Other Contributors:
      • Kenneth E.L. McColl

    Dear Editor

    We read with interest the paper by Mera et al1 on the effect of eradicating H. pylori infection on precancerous gastric lesions. However, we have concern regarding the extent to which the limited data provided in the paper support the authors’ conclusions of regression of atrophy and intestinal metaplasia following H. pylori eradication.

    The main outcome reported was the average histological...

    Show More
    Conflict of Interest:
    None declared.